44
edits
Changes
Jump to navigation
Jump to search
Line 16:
Line 16: + + + + + Line 22:
Line 27: − + Line 28:
Line 33: − + − +
Sprague serimmune data
|-
|-
| [[User:Madprime]] || 2022-02-03 || [[File:TOEAIX_20220203.pdf]] || Moderna vaccine (two shots, plus booster)
| [[User:Madprime]] || 2022-02-03 || [[File:TOEAIX_20220203.pdf]] || Moderna vaccine (two shots, plus booster)
|-
|[[User:Sprague]]
|2022-12-14
|
|Pfizer vaccine (two shots, pre-booster)
|}
|}
None yet; [[User:Madprime]] anticipates having one as they were infected with COVID-19 (positive home antigen test on 2022-05-01).
None yet; [[User:Madprime]] anticipates having one as they were infected with COVID-19 (positive home antigen test on 2022-05-01).
=Other results=
= Other results=
In addition to COVID-19 related antibody analyses, the study shares research analysis of antibodies related to infectious diseases (Lyme Disease, Ehrlichiosis, Anaplasmosis, Babesiosis, Chagas Disease) and autoimmune conditions (Celiac Disease).
In addition to COVID-19 related antibody analyses, the study shares research analysis of antibodies related to infectious diseases (Lyme Disease, Ehrlichiosis, Anaplasmosis, Babesiosis, Chagas Disease) and autoimmune conditions (Celiac Disease).
{| class="wikitable"
{| class="wikitable"
|-
|-
! Individual !! Date !! Report !! Notes
!Individual!!Date!!Report!!Notes
|-
|-
| [[User:Madprime]] || 2022-02-03 || [[File:TOEAIX_Expanded_20220203.pdf]] || No medical history related to these analyses.
| [[User:Madprime]]||2022-02-03||[[File:TOEAIX_Expanded_20220203.pdf]]||No medical history related to these analyses.
|}
|}